To investigate more globally the transcriptional crosstalk between p53 and NFκB we performed a proof of concept study using breast cancer-derived MCF7 cells treated with Doxorubicin, Tumor Necrosis Factor alpha (TNF⍺) and a combination of the two compounds (Doxo+TNF⍺). Here, TP53 is linked to breast cancer.